103 related articles for article (PubMed ID: 20022305)
1. Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis.
Parietti V; Chifflot H; Sibilia J; Muller S; Monneaux F
Clin Immunol; 2010 Mar; 134(3):331-9. PubMed ID: 20022305
[TBL] [Abstract][Full Text] [Related]
2. Profound invariant natural killer T-cell deficiency in inflammatory arthritis.
Tudhope SJ; von Delwig A; Falconer J; Pratt A; Woolridge T; Wilson G; Isaacs JD; Ng WF
Ann Rheum Dis; 2010 Oct; 69(10):1873-9. PubMed ID: 20444757
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.
Leandro MJ; Cambridge G; Ehrenstein MR; Edwards JC
Arthritis Rheum; 2006 Feb; 54(2):613-20. PubMed ID: 16447239
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate genes for rituximab response in rheumatoid arthritis patients by microarray expression profiling in blood cells.
Julià A; Barceló M; Erra A; Palacio C; Marsal S
Pharmacogenomics; 2009 Oct; 10(10):1697-708. PubMed ID: 19842941
[TBL] [Abstract][Full Text] [Related]
5. Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.
Teng YK; Levarht EW; Toes RE; Huizinga TW; van Laar JM
Ann Rheum Dis; 2009 Jun; 68(6):1011-6. PubMed ID: 18647852
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
[TBL] [Abstract][Full Text] [Related]
7. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis.
Roll P; Palanichamy A; Kneitz C; Dorner T; Tony HP
Arthritis Rheum; 2006 Aug; 54(8):2377-86. PubMed ID: 16869000
[TBL] [Abstract][Full Text] [Related]
8. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
[TBL] [Abstract][Full Text] [Related]
9. Inverse association of peripheral blood CD4(+) invariant natural killer T cells with atopy in human asthma.
Koh YI; Shim JU; Wi JO; Han ER; Jin NC; Oh SH; Park CK; Park DJ
Hum Immunol; 2010 Feb; 71(2):186-91. PubMed ID: 19879910
[TBL] [Abstract][Full Text] [Related]
10. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy.
Bokarewa M; Lindholm C; Zendjanchi K; Nadali M; Tarkowski A
Scand J Immunol; 2007 Oct; 66(4):476-83. PubMed ID: 17850593
[TBL] [Abstract][Full Text] [Related]
12. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
van Assen S; Holvast A; Benne CA; Posthumus MD; van Leeuwen MA; Voskuyl AE; Blom M; Risselada AP; de Haan A; Westra J; Kallenberg CG; Bijl M
Arthritis Rheum; 2010 Jan; 62(1):75-81. PubMed ID: 20039396
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two flow cytometric methods for detection of human invariant natural killer T cells (iNKT).
Fereidouni M; Jabbari Azad F; Mahmoudi M; Varasteh A; Farid Hosseini R
Iran J Immunol; 2010 Mar; 7(1):1-7. PubMed ID: 20371914
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.
Roll P; Dörner T; Tony HP
Arthritis Rheum; 2008 Jun; 58(6):1566-75. PubMed ID: 18512772
[TBL] [Abstract][Full Text] [Related]
15. Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis.
Nissinen R; Leirisalo-Repo M; Peltomaa R; Palosuo T; Vaarala O
Ann Rheum Dis; 2004 Jun; 63(6):681-7. PubMed ID: 15140775
[TBL] [Abstract][Full Text] [Related]
16. Rituximab therapy in patients with resistant rheumatoid arthritis: real-life experience.
Jois RN; Masding A; Somerville M; Gaffney K; Scott DG
Rheumatology (Oxford); 2007 Jun; 46(6):980-2. PubMed ID: 17384180
[TBL] [Abstract][Full Text] [Related]
17. [Administration of monoclonal antibodies to B-lymphocytes (rituximab) in rheumatoid arthritis in Russia].
Nasonov EL; Lukina GV; Sigidin IaA; Bazevich LA; Zlobina TI; Kamalova RG; Kniazeva LA; Mazurov VI; Men'shikova LV; Sizikov AE; Smirnova EA; Fofonova NA; Shabalina TV; Shkil' NV; Iakushin SS
Ter Arkh; 2008; 80(8):57-62. PubMed ID: 18807543
[TBL] [Abstract][Full Text] [Related]
18. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood.
Lawson CA; Brown AK; Bejarano V; Douglas SH; Burgoyne CH; Greenstein AS; Boylston AW; Emery P; Ponchel F; Isaacs JD
Rheumatology (Oxford); 2006 Oct; 45(10):1210-7. PubMed ID: 16571607
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis.
Korhonen R; Moilanen E
Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):13-21. PubMed ID: 19686542
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy.
Leandro MJ; Cooper N; Cambridge G; Ehrenstein MR; Edwards JC
Rheumatology (Oxford); 2007 Jan; 46(1):29-36. PubMed ID: 16735454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
